MedPath

AYVAKYT

AYVAKYT

Approved
DIN Number

02551764

Drug Class

Human

Market Date

Dec 2, 2024

Company
HC

Blueprint Medicines

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02551764
AIG Number0166224001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX18 AVAPRITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AVAPRITINIBActive
Strength: 25 MG
Monograph: AVAPRITINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.